You are here: Industry Insights > GMP

News List

Biotechpharma to Expand Process Development and GMP Manufacturing Capacity americanpharmaceuticalreview
April 18, 2019
Biotechpharma UAB announced further expansion of its fermentation capacity to 5,000 L, along with an additional state-of-the-art process development laboratory, investing more than €50 million in the expansion.
Paragon to Build Second GMP Mfg. Facility contractpharma
April 18, 2019
On the heels of its acquisition by Catalent, Paragon Bioservices, the biologics contract development and manufacturing organization (CDMO) ...
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection En-CPhI.cn
April 17, 2019
WuXi Biologics announced that its Drug Substance (DS) and Drug Product (DP) manufacturing facilities at Wuxi city successfully completed a seven-day FDA surveillance inspection by three inspectors for the production of Trogarzo™...
Almac Expands Global Analytical Services Capability contractpharma
April 16, 2019
To bolster operations at its Athlone facility.
YMC Acquires ChromaCon Biz contractpharma
April 15, 2019
Expands footprint in multi-column continuous purification technologies.
Paragon Opens New Biomanufacturing Facility in MD contractpharma
April 15, 2019
New facility is equipped with several 500L and 2000L single-use bioreactors for clinical through commercial material production...
What’s in your pellet? BioSpectra announces GMP grades of Sodium Hydroxide (NaOH) solutions without the use of pellets. cphi-online
April 11, 2019
BioSpectra announces GMP grades of Sodium Hydroxide (NaOH) solutions without the use of pellets.
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection en-cphi.cn
March 28, 2019
A subsidiary of WuXi AppTec - announces that its new drug product manufacturing facility in Shanghai Pilot Free Trade Zone has passed its first GMP inspection by the European Medical Products Agency (MPA).
Lupin’s Pune Biotech facility receives EU GMP clearance expressbpd
March 28, 2019
The GMP certification confirms that Lupin has a robust manufacturing facility that ensures consistent and controlled production as per EU quality standards.
WuXi Biologics to be the first biologics company in China approved by both the U.S. FDA and EMA en-cphi.cn
March 20, 2019
WuXi Biologics to be the first biologics company in China approved by both the U.S. FDA and EMA

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page